Gritstone bio to Participate in Upcoming Investor Conferences
20 Noviembre 2023 - 6:00AM
Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology
company working to develop the world’s most potent vaccines, today
announced that management will be participating in the following
investor conferences:
6th Annual Evercore ISI HealthCONx Conference (Fireside
Chat)Presentation Date and Time: Wednesday, November
29, 2023 at 10:00am ETSpeaker: Andrew Allen, M.D., Ph.D.,
Co-founder, President and Chief Executive
OfficerLocation: Miami, FL
35th Annual Piper Sandler Healthcare Conference
(Fireside Chat)Presentation Date and Time: Thursday,
November 30, 2023 at 10:00am ETSpeaker: Andrew Allen, M.D.,
Ph.D., Co-founder, President and Chief Executive
OfficerLocation: New York, NY
First Annual Goldman Sachs Catalyst Clinic (Fireside
Chat)Presentation Date and Time: Tuesday, December 5
at 11:00am ETSpeaker: Andrew Allen, M.D., Ph.D., Co-founder,
President and Chief Executive OfficerLocation: Virtual
Live webcasts of the fireside chats will be available via
https://ir.gritstonebio.com/investors/events. Archived replays will
be accessible for 30 days following each event.
About Gritstone bioGritstone bio, Inc. (Nasdaq:
GRTS) is a clinical-stage biotechnology company that aims to
develop the world’s most potent vaccines. We leverage our
innovative vectors and payloads to train multiple arms of the
immune system to attack critical disease targets. Independently and
with our collaborators, we are advancing a portfolio of product
candidates to treat and prevent viral diseases and solid tumors in
pursuit of improving patient outcomes and eliminating disease.
www.gritstonebio.com
Gritstone ContactsInvestors:George E.
MacDougallGritstone bio, Inc.ir@gritstone.com
Media:Dan Budwick1AB(973) 271-6085dan@1abmedia.com
Gritstone bio (NASDAQ:GRTS)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
Gritstone bio (NASDAQ:GRTS)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024